ADVANCED SEARCH
HOME
ABOUT US
AGENCIES
NEWS RELEASES
MULTIMEDIA
SPECIAL EVENTS
TOOLS
CONTACT
News Releases
Health & Medical
Translations:
All (English)
Chinese - Simplified
Chinese - Traditional
Hindi
Indonesian
Japanese
Korean
Malay
Pashto
Thai
Urdu
Vietnamese
Arabic
Bulgarian
Burmese
Canadian French
Czech
Danish
Dutch
Estonian
Finnish
French
German
Greek
Hebrew
Hungarian
Italian
Latvian
Lithuanian
Norwegian
Polish
Portuguese (European)
Portuguese (Latin American)
Russian
Slovakian
Spanish (European)
Spanish (Latin American)
Swedish
Turkish
Health & Medical Results: 1980 item(s)
Suvoda Launches eCOA-Specific Language and Design Toolkit as S...
- 07 December 2022 11:00
PHILADELPHIA, Dec. 7, 2022 /PRNewswire- AsiaNet/ -- --Practical, innovative functionality seeks to alleviate eCOA burdens, reduce time-to-launch, and improve site, clinician, and patient experience. Suvoda LLC, a global clinical trial technology company that specializes in complex studies in the...
Turn Biotechnologies Changes Paradigm in Skin Rejuvenation
- 07 December 2022 01:00
MOUNTAIN VIEW, Calif., Dec. 6, 2022 /PRNewswire-AsiaNet/ -- -- Data unveiled at four industry conferences suggest a single ERA treatment may be more effective than combination therapies used today -- Biomarker analysis demonstrates ERA's regenerative impact on fibroblast prolifera...
Sai Life Sciences releases its Sustainability Report 2022
- 05 December 2022 22:04
HYDERABAD, India, Dec. 5, 2022 /PRNewswire-AsiaNet/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization [https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=sustainability-report-2022](CRO/ CDMO), today announced the release of its Sust...
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES...
- 03 December 2022 04:39
MIAMI, Dec. 3, 2022 /PRNewswire-AsiaNet/ -- -- The Center at Rush University Will Be Directed By Dr. Elizabeth Berry-Kravis The Foundation for Angelman Syndrome Therapeutics (FAST) announced today a $5 million gift to establish the new clinical trial and translational research effort for...
Sirolimus Coated Balloon in BTK Treatment makes a bold presenc...
- 03 December 2022 00:53
TAMPA, Fla., Dec. 2, 2022 /PRNewswire-AsiaNet/ -- VEITH 2022 witnessed a surge of supporting clinical data for Sirolimus Coated Balloon in the treatment of Below-the-Knee (BTK) disease. Concept Medical Inc. [https://www.conceptmedical.com/] hosted a lunch symposium titled 'Sirolimus Coated Ba...
Encore Medical Education announces publication of the Official...
- 01 December 2022 18:45
SAN ANTONIO, Dec. 1, 2022 /PRNewswire-AsiaNet/ -- - Best of SABCS(R) News Highlights coverage will provide daily expert video summaries along with original presentation slides of the most significant breast cancer trials for oncologists worldwide. Encore Medical Education [http://www.encor...
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
- 01 December 2022 11:00
DUBLIN, Dec. 1, 2022 /PRNewswire-AsiaNet/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Cosmo Bio. This is a non-exclusive license agreement granting Japan's Cosmo Bio access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle C...
LUCIDITY phase 3 topline data presented at CTAD for HMTM – the...
- 01 December 2022 09:13
ABERDEEN, Scotland and SINGAPORE, Nov. 30, 2022 /PRNewswire-AsiaNet/ -- - Tau aggregation inhibitor, HMTM, is an oral drug with a strong safety profile, having no risk of amyloid related imaging abnormalities - Topline results for the Phase 3 study, LUCIDITY, were shared at the Clinical Trials in Alzheimer's Diseas...
Menarini Group Presents Updated Results from Pivotal Phase 3 E...
- 01 December 2022 03:52
FLORENCE, Italy, November, 30, 2022, /PRNewswire-AsiaNet/-- • Elacestrant demonstrated longer progression-free survival (PFS) vs SOC endocrine therapy with medians up to 8.6 months, positively associated with the duration of prior treatment with CDK4/6 inhibitors • Elacestrant side effects were manageable...
Global alliance of heart patient organizations unveils new Glo...
- 30 November 2022 19:00
GALWAY, Ireland, Nov. 30, 2022 /PRNewswire-AsiaNet/-- The Global Heart Hub has today launched its Global Cholesterol Action Plan[https://invisiblenation.globalhearthub.org/] to reduce the impact of unhealthy cholesterol levels . Presented at their annual UNITE Summit , the Action Plan follows and bui...
Page 9 of 198
...
4
5
6
7
8
9
10
11
12
13
...
Go to page
All Categories
Automotive, Transport & Logistics
Business & Finance
Education
Energy, Mining & Resources
Environment
Events
General News
Health & Medical
Manufacturing
Media, Entertainment & Fashion
Property & Development
Retail & Hospitality
Science
Social Welfare
Sport
Technology & Innovation
Tourism & Leisure
Advanced Search
Search for either:
News Releases
Translations:
All (English)
Chinese - Simplified
Chinese - Traditional
Hindi
Indonesian
Japanese
Korean
Malay
Pashto
Thai
Urdu
Vietnamese
Arabic
Bulgarian
Burmese
Canadian French
Czech
Danish
Dutch
Estonian
Finnish
French
German
Greek
Hebrew
Hungarian
Italian
Latvian
Lithuanian
Norwegian
Polish
Portuguese (European)
Portuguese (Latin American)
Russian
Slovakian
Spanish (European)
Spanish (Latin American)
Swedish
Turkish
or
Multimedia
Type:
all
images
audio
video
mnr
other
Category:
All Categories
Automotive, Transport & Logistics
Business & Finance
Education
Energy, Mining & Resources
Environment
Events
General News
Health & Medical
Manufacturing
Media, Entertainment & Fashion
Property & Development
Retail & Hospitality
Science
Social Welfare
Sport
Technology & Innovation
Tourism & Leisure
Keywords:
Date range:
All
Range
From:
Open the calendar popup.
<<
<
September 2024
>
>>
M
T
W
T
F
S
S
35
26
27
28
29
30
31
1
36
2
3
4
5
6
7
8
37
9
10
11
12
13
14
15
38
16
17
18
19
20
21
22
39
23
24
25
26
27
28
29
40
30
1
2
3
4
5
6
To:
Open the calendar popup.
<<
<
September 2024
>
>>
M
T
W
T
F
S
S
35
26
27
28
29
30
31
1
36
2
3
4
5
6
7
8
37
9
10
11
12
13
14
15
38
16
17
18
19
20
21
22
39
23
24
25
26
27
28
29
40
30
1
2
3
4
5
6
Entries per page: